EU’s new Joint Clinical Assessment (JCA): will patients have a say?

Mapping of the funding flows associated with the introduction of CAR-T treatments for DLBCL in the Chinese healthcare system

The 5 ‘innovation areas’ driving success in chronic diseases

Can the patient pathway provide a route to success?

Development and testing of a payer value story / value messages

Assessment of the global opportunity for novel biomarkers for atrial fibrillation diagnosis – Evaluation of the Chinese landscape